Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of estradiol-containing contraceptive vaginal rings for primary dysmenorrhea
NL-OMON36928Phase 2Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of nomegestrol, estradiol and etonogestrel in primary dysmenorrhea (PD) (5 arms), sponsored by Merck & Co. Primary endpoint: Primary efficacy endpoint. Started Feb 2013; status: active, not recruiting.
02
Drugs
nomegestrolestradioletonogestrel
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NL-OMON36928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36928.